Literature DB >> 34495530

Glycosphingolipids.

Elena Chiricozzi1, Massimo Aureli1, Laura Mauri1, Erika Di Biase1, Giulia Lunghi1, Maria Fazzari1, Manuela Valsecchi1, Emma Veronica Carsana1, Nicoletta Loberto1, Alessandro Prinetti1, Sandro Sonnino2.   

Abstract

Glycosphingolipids are amphiphilic plasma membrane components formed by a glycan linked to a specific lipid moiety. In this chapter we report on these compounds, on their role played in our cells to maintain the correct cell biology.In detail, we report on their structure, on their metabolic processes, on their interaction with proteins and from this, their property to modulate positively in health and negatively in disease, the cell signaling and cell biology.
© 2021. The Author(s), under exclusive license to Springer Nature Switzerland AG.

Entities:  

Keywords:  Cancer; Ceramide; Glycosphingolipids; Neurodegeneration; Neuroprotection; Sphingosine

Mesh：

Substances：

Year:  2021        PMID： 34495530     DOI： 10.1007/978-3-030-70115-4_3

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN： 0065-2598            Impact factor:   3.650


  201 in total

1.  Gangliosides as a potential new class of stem cell markers: the case of GD1a in human bone marrow mesenchymal stem cells.

Authors:  Sonia Bergante; Enrica Torretta; Pasquale Creo; Nadia Sessarego; Nadia Papini; Marco Piccoli; Chiara Fania; Federica Cirillo; Erika Conforti; Andrea Ghiroldi; Cristina Tringali; Bruno Venerando; Adalberto Ibatici; Cecilia Gelfi; Guido Tettamanti; Luigi Anastasia
Journal:  J Lipid Res       Date:  2014-01-21       Impact factor: 5.922

2.  Gangliosides in the brain in adult Down's syndrome and Alzheimer's disease.

Authors:  B W Brooksbank; J McGovern
Journal:  Mol Chem Neuropathol       Date:  1989-12

3.  Expression of leukocyte differentiation antigens during the differentiation of HL-60 cells induced by 1,25-dihydroxyvitamin D3: comparison with the maturation of normal monocytic and granulocytic bone marrow cells.

Authors:  D Brackman; F Lund-Johansen; D Aarskog
Journal:  J Leukoc Biol       Date:  1995-11       Impact factor: 4.962

4.  GM1 inhibits amyloid beta-protein-induced cytokine release.

Authors:  T Ariga; R K Yu
Journal:  Neurochem Res       Date:  1999-02       Impact factor: 3.996

Review 5.  Sorting of lysosomal proteins.

Authors:  Thomas Braulke; Juan S Bonifacino
Journal:  Biochim Biophys Acta       Date:  2008-11-12

6.  Ganglioside-mediated modulation of cell growth. Specific effects of GM3 on tyrosine phosphorylation of the epidermal growth factor receptor.

Authors:  E G Bremer; J Schlessinger; S Hakomori
Journal:  J Biol Chem       Date:  1986-02-15       Impact factor: 5.157

7.  Gangliosides prevent excitotoxicity through activation of TrkB receptor.

Authors:  Alessia Bachis; Stuart J Rabin; Marina Del Fiacco; Italo Mocchetti
Journal:  Neurotox Res       Date:  2002-05       Impact factor: 3.911

8.  Elimination of GD3 synthase improves memory and reduces amyloid-beta plaque load in transgenic mice.

Authors:  Alexandra Bernardo; Fiona E Harrison; Meghan McCord; Jiali Zhao; Aleksandra Bruchey; Sean S Davies; L Jackson Roberts; Paul M Mathews; Yasuji Matsuoka; Toshio Ariga; Robert K Yu; Rebecca Thompson; Michael P McDonald
Journal:  Neurobiol Aging       Date:  2008-02-06       Impact factor: 4.673

9.  Mass Spectrometric Imaging of Ceramide Biomarkers Tracks Therapeutic Response in Traumatic Brain Injury.

Authors:  Damon C Barbacci; Aurelie Roux; Ludovic Muller; Shelley N Jackson; Jeremy Post; Kathrine Baldwin; Barry Hoffer; Carey D Balaban; J Albert Schultz; Shawn Gouty; Brian M Cox; Amina S Woods
Journal:  ACS Chem Neurosci       Date:  2017-08-14       Impact factor: 4.418

10.  Disease-modifying effects of ganglioside GM1 in Huntington's disease models.

Authors:  Melanie Alpaugh; Danny Galleguillos; Juan Forero; Luis Carlos Morales; Sebastian W Lackey; Preeti Kar; Alba Di Pardo; Andrew Holt; Bradley J Kerr; Kathryn G Todd; Glen B Baker; Karim Fouad; Simonetta Sipione
Journal:  EMBO Mol Med       Date:  2017-11       Impact factor: 12.137
View more
  1 in total

1.  β-Glucocerebrosidase Deficiency Activates an Aberrant Lysosome-Plasma Membrane Axis Responsible for the Onset of Neurodegeneration.

Authors:  Giulia Lunghi; Emma Veronica Carsana; Nicoletta Loberto; Laura Cioccarelli; Simona Prioni; Laura Mauri; Rosaria Bassi; Stefano Duga; Letizia Straniero; Rosanna Asselta; Giulia Soldà; Alessio Di Fonzo; Emanuele Frattini; Manuela Magni; Nara Liessi; Andrea Armirotti; Elena Ferrari; Maura Samarani; Massimo Aureli
Journal:  Cells       Date:  2022-07-29       Impact factor: 7.666
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.